Author

H. Mukai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:metagenomics· 1

Frequent Co-Authors

A. T.-J. Kwon· 1 shared B. Kaczkowski· 1 shared D. Bolidong· 1 shared E. Arner· 1 shared H. Hurutani· 1 shared H. Suzuki· 1 shared H. Takamiya· 1 shared K. Matoba· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. T.-J. Kwon

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Surface-engineered extracellular vesicles to modulate antigen-specific T cell expansion for cancer immunotherapy

X. Lyu, T. Yamano, S. Imai, T. V. Le, D. Bolidong, M. Ueda, S. Warashina, H. Mukai, S. Hayashi, K. Matoba, T. Nishino, R. Hanayama

The paper develops antigen-presenting extracellular vesicles (AP-EVs) engineered to enhance T cell expansion and anticancer immunity through combined immunotherapy.

bioRxiv · Sep 25, 2023 · PreprintBioengineering

Ultra-small cells and DPANN genome unveiled inside an extinct vent chimney

H. Takamiya, M. Kouduka, H. Hurutani, H. Mukai, T. Yamamoto, S. Kato, Y. Kodama, N. Tomioka, M. Ito, Y. Suzuki

The paper identifies ultra-small cells in an extinct hydrothermal vent chimney, associated with Pacearchaeota, using genome-resolved metagenomics and nanocrystal analysis.

bioRxiv · Mar 8, 2021 · PreprintMicrobiology

Efficient Development of Platform Cell Lines Using CRISPR-Cas9 and Transcriptomics Analysis

A. T.-J. Kwon, K. Mohri, S. Takizawa, T. Arakawa, M. Takahashi, B. Kaczkowski, M. Furuno, H. Suzuki, S. Tagami, H. Mukai, E. Arner

The paper develops CRISPR-Cas9 mutants of U87MG cells to create platform cell lines for drug testing, finding that transcriptomic analysis helps identify clones with minimal phenotypic divergence from wild type.

bioRxiv · Sep 16, 2020 · PreprintBioengineering